Correlation of sdLDL-C with cardiometabolic risk indices in women with subclinical hypothyroidism– A cross-sectional study
Keywords:Subclinical hypothyroidism, sdLDL-C, cardiometabolic risk indices, atherogenic index
Introduction and Aim: Subclinical hypothyroidism (SCH) characterised by normal free thyroxine (FT4), “free triiodothyronine (FT3)”, and raised serum TSH, is an early stage of mild thyroid hormone deficiency. A change in the lipid profile most often observed in SCH is mainly caused by increased serum levels of Triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C), whereas high-density lipoprotein cholesterol (HDL-C) levels can be normal or elevated. Studies on small dense Low Density Lipoprotein – Cholesterol (sdLDL-C), associated with CVD risk are few. The aim of this study was to estimate serum sdLDL-C and find its correlation with thyroid profile (FT4 and TSH) and cardiometabolic risk indicators in female subjects with subclinical hypothyroidism.
Materials and Methods: The study had 112 female participants in total. After screening, subjects were divided into two groups. Control group (euthyroid) and study group (SCH). Age, TSH, FT4, TC, TG, HDL-C, LDL-C, sdLDL-C & Lipid ratios “(TC/HDL-C, LDL-C/HDL-C”, “Log TG/ HDL-C)” were examined and compared between the two groups.
Results: The correlation of sdLDL-C with TSH, FT4, lipid parameters & lipid ratios were studied. TG, TC, HDL-C, and LDL-C were not clinically significant. While sdLDL-C and lipid ratios had a statistical decrease, it was not clinically significant. A highly significant negative association between sdLDL-C, other lipid parameters, except HDL-C, lipid ratios are observed in the study group.
Conclusion: As anticipated, the current investigation did not demonstrate any statistically significant improvement in the sdLDL-C as a better predictor of CVD risk. No apparent lipid abnormalities were also seen in women, in the age group of 20-40 years as observed in the correlation studies. However, measurement of AIP along with FT4 would make a better assessment of CVD risk.
Al-Fatlawi, A. C. An evaluation of blood glucose and lipid profile in female hypothyroidism patients in Kerbala province, Iraq. Biomedicine. 2022 Jul 3;42(3):556-560.
Pearce, E. N. Hypothyroidism and dyslipidaemia: modern concepts and approaches. Current cardiology reports. 2004 Nov; 6(6):451-456.
Stael, B., Tol, A.V., Chan, L., Will, H., Verhoeven, G., Auwerx, J. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low-density lipoprotein receptor in rats. Endocrinology. 1990 Sep 1;127(3):1144-1152.
Liberopoulos, E. N., Elisaf, M.S. Dyslipidaemia in patients with thyroid disorders. HORMONES-ATHENS-. 2002 Oct 15;1:218-223.
Singh, S.K., Reddy, D.V. Indian consensus for management of hypothyroidism. Medicine update. JAPI. 2002;12:389-394.
Jayasingh, I.A., Puthuran, P. Subclinical hypothyroidism and the risk of hypercholesterolemia. Journal of family medicine and primary care. 2016 Oct; 5(4):809.
Saric, M.S., Jurasic, M.J., Sovic, S., Kranjcec, B., Glivetic, T., Demarin, V. Dyslipidemia in subclinical hypothyroidism requires assessment of small dense low density lipoprotein cholesterol (sdLDL-C). Rom J Intern Med. 2017 Sep 26;55(3):159-166.
Ranjan, A., Sudha, K., Nandini, M., Durgarao, Y. Novel evidence of relationship between serum vitamin B12 and folate with total vitamin D in subclinical hypothyroidism. Biomedicine. 2020 Nov 9;40(3):278-280.
Lioudaki, E., Mavroeidi, N.G., Mikhailidis, D.P., Ganotakis, E.S. Subclinical hypothyroidism and vascular risk: an update. Hormones (Athens). 2013 Oct-Dec;12(4):495-506.
Biondi, B., Cappola, A.R., Cooper, D.S. Subclinical Hypothyroidism: A Review. JAMA. 2019 Jul 9;322(2):153-160.
Iqbal, A., Jorde, R., Figenschau, Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med. 2006 Jul; 260(1):53-61.
Kumar, A., Prabhu, M. M., Bhat, N., Stanley, W. A study of cardiovascular profile in patients with primary hypothyroidism. Biomedicine. 2022 Sep 12;42(4):766-770.
Lekakis, J., Papamichael, C., Alevizaki, M., Piperingos, G., Marafelia, P., Mantzos, J., Stamatelopoulos, S., & Koutras, D. A. (1997). Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid: official journal of the American Thyroid Association, 7(3), 411–414. https://doi.org/10.1089/thy.1997.7.411
Papaioannou, G.I., Lagasse, M., Mather, J. F., Thompson, P.D. Treating hypothyroidism improves endothelial function. Metabolism 2004; 53 (3): 278-279.
O’Brien, T., Dinneen, S.F., O’Brien, P.C., Palumbo, P.J. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993;68:860 866.
Sacks, F.M., Campos, H. Clinical review 163: Cardiovascular endocrinology 4: Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 2003; 88:4525-4532.
Third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
Baliarsingh, S., Sharma, N., Mukherjee, R. Serum uric acid: Marker for atherosclerosis as it is positively associated with “atherogenic index of plasma”. Arch Physiol Biochem 2013;119:27 31.
Rizos, C.V., Elisaf, M.S., Liberopoulos, E.N. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84.
Liu, X.L., He, S., Zhang, S.F., Wang, J., Sun, X.F., Gong, C.M., et al., Alteration of lipid profile in subclinical hypothyroidism: A meta analysis. Med Sci Monit 2014;20:1432 1441.
James, S.R., Ray, L., Ravichandran, K., Nanda, S.K. High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk. Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):656-661.
Hueston, W. J., Pearson, W. S. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med. 2004; 2:351-355.
Luboshitzky, R., Aviv, A., Herer, P., Lavie, L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002;12:421 425.
Walsh, J.P., Bremner, A.P., Bulsara, M.K., et al. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf) 2005; 63: 670-675.
Griffin BA. Lipoprotein atherogenicity: an overview of current mechanisms. P Nutr Soc 1999; 58: 163-169.
Campos, H., Blijlevens, E., McNamara, J.R., Ordovas, J.M., Wilson, P.W.F., Schaeferm, E.J. LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb, 1992; 12: 1410-1419.
Hoogeveen, R.C., Gaubatz, J.W., Sun, W., Dodge, R.C., Crosby, J.R., Jiang, J., et al., Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol, 2014; 34: 1069-1077.
Gentile, M., Panico, S., Mattiello, A., Ubaldi, S., Iannuzzo, G., De Michele, M., et al., Association between small dense LDL and early atherosclerosis in a sample of menopausal women. Clin Chim Acta, 2013; 426: 1-5.
Kim, C.S., Kang, J.G., Lee, S.J. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans. Clin Endocrinol (Oxf) 2009; 71: 130-136.
Marwaha, R.K., Tandon, N., Garg, M.K., Kanwar, R., Sastry, A., Narang, A., et al., Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin Biochem 2011; 44:1214 1217.
How to Cite
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.